Discover more about NCATS, its director and staff, and job and training opportunities.
-
Research
-
Center Overview
Resources Highlight Attributes of Translational Scientists
We created a new video and worked with Translation Together on a consensus paper to raise awareness of translational science and present the skills translational scientists use to transform medical discoveries into treatments and cures.
Sharing Patient & Community Perspectives at NCATS Day 2018
NCATS Day is a cornerstone of the Center’s efforts to engage and collaborate with a variety of diverse stakeholders, particularly patients and their communities, to advance translational science.
Translating Translation
NCATS Director Christopher P. Austin, M.D., defines, distinguishes and explores the promise of translation, translational research and translational science.
About the CenterFind details about NCATS’ organizational structure, operating budget and more.
Director’s CornerAccess monthly messages from the NCATS director addressing challenges and ongoing activities in translation.
NCATS Staff ProfilesLearn more about the experts and NCATS, including research/professional interests and recent publications.
Strategic PlanExplore the Center’s strategic planning process, and find out how you can participate.
Find details about NCATS’ organizational structure, operating budget and more.
Access monthly messages from the NCATS director addressing challenges and ongoing activities in translation.
Learn more about the experts and NCATS, including research/professional interests and recent publications.
Explore the Center’s strategic planning process, and find out how you can participate.
Contact Us
NCATS Communications Branch
301-435-0888
info@ncats.nih.govConnect With Us
Discover all of the ways you can connect with NCATS and stay up-to-date on the latest news and information.
Learn more about NCATS’ Achievements in Advancing Translational Sciences.
Organizational Chart
NCATS is all about getting more treatments to more patients more quickly. The Center's organizational structure (PDF - 89KB) includes diverse representation, including those from disease advocacy organizations and private equity firms, along with renowned scholars in translational science and regulatory review.
-
